Aadi Bioscience

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$7,212
$6,179
$5,353
$6,326
Gross Profit
6,408
5,401
4,701
5,399
EBITDA
-13,413
-14,475
-18,181
-16,168
EBIT
-13,460
-14,524
-18,231
-16,212
Net Income
-12,546
-14,583
-18,289
-16,268
Net Change In Cash
7,212
6,179
5,353
6,326
Free Cash Flow
-20,484
-9,698
-20,392
-10,460
Cash
30,537
41,139
53,780
62,888
Basic Shares
27,041
27,010
26,980
26,965

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$24,354
$15,216
$1,000
$14,000
Gross Profit
21,545
13,881
724
13,824
EBITDA
-65,365
-60,124
-109,147
-2,485
EBIT
-65,534
-60,283
-109,423
-2,661
Net Income
-65,765
-57,010
-110,090
-3,478
Net Change In Cash
24,354
15,216
1,000
14,000
Cost of Revenue
144,534
4,080
Free Cash Flow
-63,635
-50,084
-22,469
-12,701
Cash
62,888
39,019
148,989
4,455
Basic Shares
26,917
22,511
8,923
2,542

Earnings Calls

Quarter EPS
2024-09-30
-$0.46
2024-06-30
-$0.54
2024-03-31
-$0.68
2023-12-31
-$0.60